Article ID Journal Published Year Pages File Type
8242385 International Journal of Radiation Oncology*Biology*Physics 2007 7 Pages PDF
Abstract
Conclusions: The combination of bevacizumab, capecitabine, oxaliplatin, and radiation therapy in rectal cancer was tolerable, with encouraging response rates. Further investigation with this regimen is being pursued in a Phase II setting.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Bevacizumab, Oxaliplatin, and Capecitabine With Radiation Therapy in Rectal Cancer: Phase I Trial Results
Authors
, , , , , , , , , , , ,